IL218996A - Methods for producing and preserving populations of ectodermal or mesodermal / endodermal origin cells - Google Patents

Methods for producing and preserving populations of ectodermal or mesodermal / endodermal origin cells

Info

Publication number
IL218996A
IL218996A IL218996A IL21899612A IL218996A IL 218996 A IL218996 A IL 218996A IL 218996 A IL218996 A IL 218996A IL 21899612 A IL21899612 A IL 21899612A IL 218996 A IL218996 A IL 218996A
Authority
IL
Israel
Prior art keywords
ectodermal
mesodermal
population
maintaining
generating
Prior art date
Application number
IL218996A
Other languages
English (en)
Hebrew (he)
Other versions
IL218996A0 (en
Inventor
A Blak Alexandra
A Louis Sharon
Original Assignee
Stemcell Tech Inc
A Blak Alexandra
A Louis Sharon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Tech Inc, A Blak Alexandra, A Louis Sharon filed Critical Stemcell Tech Inc
Publication of IL218996A0 publication Critical patent/IL218996A0/en
Publication of IL218996A publication Critical patent/IL218996A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/32—Polylysine, polyornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL218996A 2009-10-13 2012-04-02 Methods for producing and preserving populations of ectodermal or mesodermal / endodermal origin cells IL218996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25113009P 2009-10-13 2009-10-13
US35494710P 2010-06-15 2010-06-15
PCT/CA2010/001610 WO2011044684A1 (en) 2009-10-13 2010-10-13 Manipulation of osmolality for differentiating stem cells

Publications (2)

Publication Number Publication Date
IL218996A0 IL218996A0 (en) 2012-06-28
IL218996A true IL218996A (en) 2017-04-30

Family

ID=43855139

Family Applications (1)

Application Number Title Priority Date Filing Date
IL218996A IL218996A (en) 2009-10-13 2012-04-02 Methods for producing and preserving populations of ectodermal or mesodermal / endodermal origin cells

Country Status (7)

Country Link
US (1) US10913929B2 (cg-RX-API-DMAC7.html)
EP (1) EP2488631B1 (cg-RX-API-DMAC7.html)
JP (1) JP5843775B2 (cg-RX-API-DMAC7.html)
CN (1) CN102762718B (cg-RX-API-DMAC7.html)
AU (1) AU2010306377B2 (cg-RX-API-DMAC7.html)
IL (1) IL218996A (cg-RX-API-DMAC7.html)
WO (1) WO2011044684A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9708582B2 (en) * 2009-10-13 2017-07-18 Stemcell Technologies Inc. Method of differentiating stem cells
JP2013528062A (ja) 2010-06-11 2013-07-08 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Xyes細胞からの繁殖可能なxy雌動物の生成
CN102851314A (zh) * 2011-07-01 2013-01-02 中国科学院上海药物研究所 诱导性多能干细胞的制备方法和用于制备诱导性多能干细胞的培养基
AU2012332269B2 (en) * 2011-11-04 2018-05-31 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (DA) neurons for engraftment
US20150119327A1 (en) * 2012-04-25 2015-04-30 The Regents Of The University Of California Drug screening platform for rett syndrome
WO2014143383A1 (en) 2013-03-13 2014-09-18 Agilent Technologies, Inc. Transposome tethered to a gene delivery vehicle
PL3008172T3 (pl) 2013-06-11 2020-09-21 Ncardia B.V. Kompozycje pożywki hodowlanej do dojrzewania kardiomiocytów pochodzących z pluripotencjalnych ssaczych komórek macierzystych
MX388127B (es) 2013-12-11 2025-03-19 Regeneron Pharma Metodos y composiciones para la modificacion dirigida de un genoma.
DK3161128T3 (en) 2014-06-26 2018-11-05 Regeneron Pharma METHODS AND COMPOSITIONS FOR TARGETED GENTICAL MODIFICATIONS AND PROCEDURES FOR USE THEREOF
CN104293730B (zh) * 2014-09-23 2017-07-28 云南中科灵长类生物医学重点实验室 多能干细胞体外定向分化为心肌细胞的方法
BR112017007770A2 (pt) 2014-10-15 2018-01-16 Regeneron Pharma cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
WO2016086092A1 (en) 2014-11-25 2016-06-02 The Penn State Research Foundation Chemical reprogramming of human glial cells into neurons for brain and spinal cord repair
CN104782583B (zh) * 2015-04-29 2017-04-12 中国农业科学院兰州兽医研究所 一种棘球蚴体外三维培养模型及其应用
KR102382458B1 (ko) 2015-09-17 2022-04-04 리제너론 파마슈티칼스 인코포레이티드 생식력 있는 xy 암컷 마우스의 생산을 위한 다능성 세포의 선택
HK1258434A1 (zh) * 2015-11-12 2019-11-08 F. Hoffmann-La Roche Ag 来自灵长类物种的标准化神经元细胞测定试验
CN105886457A (zh) * 2016-05-16 2016-08-24 中国人民解放军军事医学科学院野战输血研究所 诱导干细胞分化成外胚层祖细胞的方法
US11180733B2 (en) 2016-07-04 2021-11-23 Agency For Science, Technology And Research Method of generating mesenchymal stem cells and uses thereof
KR101810012B1 (ko) 2017-10-23 2018-01-18 차의과학대학교 산학협력단 히스톤 데아세틸라제 저해제 및 골 형성 단백질 경로 차단제를 이용한 인간-유래의 체세포로부터 역분화 만능 줄기세포의 제조방법
KR102167257B1 (ko) * 2019-05-28 2020-10-19 부산대학교 산학협력단 토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법
EP4019549B1 (en) * 2019-08-20 2025-06-04 Orizuru Therapeutics, Inc. Method for enriching cardiac myocytes
CA3167871A1 (en) * 2020-01-14 2021-07-22 Ajinomoto Co., Inc. Medium having reduced osmotic pressure
KR20230010625A (ko) 2020-03-11 2023-01-19 비트 바이오 리미티드 간 세포 생성 방법
CN114621920B (zh) * 2022-02-22 2023-09-05 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种由造血干祖细胞向nk细胞分化的方法及培养基

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221537A (en) * 1988-09-02 1993-06-22 Gerald Hecht Tissue irrigating solutions
US7439064B2 (en) 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
AU2001283504A1 (en) * 2000-07-27 2002-02-13 The Mclean Hospital Corporation Cell implantation therapy for neurological diseases or disorders
AU2003302702B2 (en) * 2002-12-05 2008-08-07 Technion Research & Development Foundation Ltd. Cultured human pancreatic islets, and uses thereof
WO2006019366A1 (en) * 2003-03-28 2006-02-23 Wisconsin Alumni Research Foundation Physiochemical culture conditions for embryonic stem cells
AU2006306809B2 (en) 2005-10-24 2012-07-19 Agency For Science, Technology And Research Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
GB0623635D0 (en) * 2006-11-27 2007-01-03 Stem Cell Sciences Uk Ltd Pluripotent cell growth media
EP2457996B1 (en) * 2007-01-03 2016-08-31 NeoStem Oncology, LLC Stem cell growth media and methods of making and using same
WO2008089355A1 (en) 2007-01-17 2008-07-24 Life Technologies Corporation Methods and compositions for improving the health of cells in culture
FI20075417A0 (fi) 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
AU2009290563A1 (en) 2008-09-15 2010-03-18 Genentech, Inc. Compositions and methods for regulating cell osmolarity

Also Published As

Publication number Publication date
US10913929B2 (en) 2021-02-09
EP2488631A1 (en) 2012-08-22
IL218996A0 (en) 2012-06-28
US20110086379A1 (en) 2011-04-14
AU2010306377A1 (en) 2012-05-10
CN102762718B (zh) 2015-06-17
AU2010306377B2 (en) 2015-01-22
EP2488631B1 (en) 2020-01-08
CN102762718A (zh) 2012-10-31
JP5843775B2 (ja) 2016-01-13
EP2488631A4 (en) 2013-06-26
JP2013507135A (ja) 2013-03-04
WO2011044684A1 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
EP2215218A4 (en) INDUCTION OF PLURIPOTENT STEM CELLS IN MESODERMIC LINES
IL276146A (en) Laboratory methods for increasing the vitality of the cells of the immune system
ZA200908904B (en) Multipotent/pluripotent cells and methods
IL241906B (en) Methods for the production and uses of pluripotent cell populations and differentiated cell populations
ZA201804932B (en) Materials and methods to enhance hematopoietic stem cells engraftment procedures
PL3323883T3 (pl) Zdefiniowane powierzchnie do hodowli komórkowej i sposoby użycia
IL212488A (en) T cells with phenotype cd34 + cd7 + cd5 + cdla - a method for making and using them for drug preparation
ZA201100758B (en) Differentiation of pluripotent stem cells
SG10202103401QA (en) Combined chemical and genetic approaches for generation of induced pluripotent stem cells
GB0907978D0 (en) Multipotent adult stem cell population
SG10201500674YA (en) Pluripotent stem cells
ZA201008392B (en) Treatment of pluripotent cells
IL216902A0 (en) Methods for culturing stem and progentitor cells
EP2723851A4 (en) SELF-RENEWING ENDODERMAL PRELIMINARY CELL LINES FROM HUMAN PLURIPOTENTIAL STEM CELLS AND METHOD OF USE THEREOF
IL214806A0 (en) Prebiotic formulations and methods of use
IL220290A0 (en) Stem cell immune modulation methods of use and apparatus
EP2456541A4 (en) PROCESS FOR OXYGEN SEPARATION AND DISTRIBUTION
SG10201405442VA (en) Method and device for using oxygen in the steam reforming of biomass
SG10201407102QA (en) Multipotent stem cells from the extrahepatic billary tree and methods of isolating same
EP2513297A4 (en) MATERIALS AND METHODS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS
WO2010141606A3 (en) Human gonadal stem cells
IL246057A (en) Peptide-presenting surfaces for long-term culture of multi-potential cells
IL216842A (en) Methods for producing hybrid / chimeric cells and their uses
ZA201207761B (en) Method for inhibiting hiv replication in mammal and human cells
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed